U.S. Transportation Stock News

Interest in TOYO (NasdaqCM:TOYO) has picked up after the stock was added to multiple Russell indexes, followed closely by the appointment of veteran finance executive Yasunari Harada as Chief Financial Officer and director. See our latest analysis for TOYO. Those index inclusions and the CFO change have arrived after a volatile stretch, with TOYO’s 30 day share price return down 57.3% and its 1 year total shareholder return at 86.94%, suggesting near term momentum has cooled while longer term...

PagSeguro Digital (PAGS) has been removed from several Russell Growth indexes, including the Russell 2000 Growth and Russell 3000 Growth. This change can influence trading flows as index funds rebalance. See our latest analysis for PagSeguro Digital. At a share price of $8.93, PagSeguro Digital has seen short term pressure, with the share price down over the past quarter, while the 1 year total shareholder return is slightly positive and the 5 year total shareholder return remains deeply...

La-Z-Boy stock has delivered a 43.7% return over the past three years, yet current valuation work suggests the shares may still trade below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach. Over the last three years, La-Z-Boy has returned 43.7%, which puts recent share performance firmly in positive territory but not at levels that clearly rule out further upside if the valuation case holds. For La-Z-Boy, the ability to keep converting earnings into steady cash flow...

Watersound Town Center expansion puts St. Joe stock in focus St. Joe (JOE) is drawing fresh investor attention after announcing a wave of new retailers, restaurants and service tenants at its Watersound Town Center open air lifestyle development in Inlet Beach, Florida. The company highlighted recent openings from national and regional apparel brands, new dining and wellness concepts, and additional office users, along with plans for two more retail buildings to break ground later this...

In late June 2026, Recursion Pharmaceuticals, Inc. was added to several Russell value and small-cap benchmarks, widening its footprint across key US equity indices and increasing its visibility to institutional and index-tracking investors. This broader index inclusion, combined with growing attention on its AI-native drug discovery platform and advancing clinical pipeline, is subtly reshaping how the market weighs Recursion’s mix of high innovation, high costs, and partnership-driven...

Index additions and sentiment shifts around DLocal DLocal (NasdaqGS:DLO) has just been added to a wide set of Russell indices. This development coincides with stronger investor interest, upbeat analyst coverage, and higher expectations for its emerging markets payments business. This combination of index inclusions and research attention has arrived alongside active insider trading plans and options for insiders to convert Class B into Class A shares. This gives investors several moving parts...

Attention around Braze (BRZE) has picked up after Goldman Sachs initiated coverage, pointing to accelerating demand for the company’s AI powered customer engagement tools, along with its recent fiscal first quarter 2027 results and billings growth. See our latest analysis for Braze. At a share price of $24.15, Braze has seen short term momentum pick up, with a 7 day share price return of 15.16% and a 90 day share price return of 7.86%. However, the year to date share price return is down...

Hamilton Lane stock has had a tough year, with a steep decline in the share price set against valuation checks that now lean toward the shares looking cheap on several measures. With the company still active in raising and deploying capital, investors are weighing whether the current level reflects a reset in expectations or a potential mispricing. Over the past 12 months, Hamilton Lane shares have fallen 42.4%, which naturally raises the question of whether sentiment has moved further than...

Tariffs back in the headlines can rattle import heavy retailers, but they can also shine a light on companies that look better prepared for higher trade frictions. With potential 10% to 12.5% duties on goods from 60 countries and renewed global tariffs on the table, some large U.S. consumer retailers with strong North American focus and healthier balance sheets may be positioned to handle higher costs more effectively than peers. This article walks through 3 stocks from a U.S. Import...

Index changes put CareTrust REIT in focus CareTrust REIT (CTRE) has been removed from several Russell growth indices, including the Russell 2000 Growth, Russell 2500 Growth, and Russell 3000 Growth benchmarks. This is a shift that can influence index-linked trading flows. See our latest analysis for CareTrust REIT. At a share price of $41.39, CareTrust REIT has a 30 day share price return of 9.01% and a year to date share price return of 13.99%. The 1 year total shareholder return of 38.69%...

Boyd Gaming Corporation was recently removed from the Russell 1000 Dynamic Index and earlier appointed retail veterans Stacia J. Andersen and George C. Roeth to its Board of Directors, bringing experience from PetSmart, Abercrombie & Fitch, Target, Clorox, and other consumer-facing companies. The index removal may influence institutional ownership patterns, while the new directors’ consumer-brand expertise could shape how Boyd Gaming refines its customer focus and growth initiatives. Next,...

Construction Partners stock has delivered very strong returns over the past three years, yet the current valuation picture is mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while the broader checks flag the shares as far from a clear bargain. Construction Partners has returned about 271.7% over the past three years, which puts extra focus on whether recent gains already reflect the business outlook. Strong demand across public infrastructure...

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has experienced a notable rise of 20%, with earnings forecasted to grow by 18% annually. In such an environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on future growth prospects.

The United States market has remained flat over the last week but is up 20% over the past year, with earnings projected to grow by 18% annually in the coming years. In this environment, identifying growth companies with strong insider ownership can be a strategic approach as it often indicates confidence from those closest to the business and potential alignment with shareholder interests.

In the last week, the United States market has stayed flat, but it is up 20% over the past year, with earnings expected to grow by 18% per annum over the next few years. Investing in penny stocks—though often considered a niche area—can still present growth opportunities, especially when these stocks are supported by strong financial health. Here, we explore several intriguing penny stocks that stand out for their financial strength and potential for long-term growth.

Legal action puts fresh focus on First BanCorp stock First BanCorp (NYSE:FBP) is in the spotlight after investors digested news of a lawsuit in the Southern District of New York related to banking services for Jeffrey Epstein, following a U.S. Virgin Islands acquisition. See our latest analysis for First BanCorp. The legal headlines arrive after a strong run in First BanCorp’s stock, with a 30 day share price return of 8.96% and a 90 day share price return of 21.73%. The 1 year total...

In recent days, Antero Resources drew fresh attention from Wall Street as Morgan Stanley reaffirmed an Overweight rating and Texas Capital initiated coverage with a positive view on the company’s Appalachian-focused natural gas and liquids portfolio. Together, these analyst updates spotlight Antero’s position as a lower-cost Appalachian pure-play with multi-year expansion potential tied to evolving global energy demand trends. Next, we’ll examine how this renewed analyst conviction around...

Confluence Investment Management has opened a new US$126.9 million position in Stanley Black & Decker (SWK), coinciding with the company amending a US$2.0b five year revolving credit facility that supports its ongoing operational reset. See our latest analysis for Stanley Black & Decker. At a share price of US$92.56, Stanley Black & Decker has delivered a 30 day share price return of 17.94% and a 90 day share price return of 36.86%. The 1 year total shareholder return of 39.65% contrasts with...

In late June 2026, Valmont Industries, Inc. (NYSE: VMI) was removed from both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, shifting its representation in key benchmark measures used by many institutional investors. At the same time, Valmont appeared in a GARP-style screen highlighting its earnings strength and financial quality, putting renewed focus on the company’s fundamentals despite its index removals. We’ll now examine how Valmont’s index removals,...

Teleflex has recently advanced its cardiovascular portfolio by starting enrollment in the large BIOMAG-III trial for its Freesolve resorbable magnesium scaffold and completing enrollment in the BIOMAG-II study, while also reporting positive four-year data from the earlier BIOMAG-I study. These clinical milestones, alongside the company’s broader portfolio reshaping and leadership changes, signal a potential shift in how Teleflex positions itself in higher-complexity interventional cardiology...

On 27 June 2026, Kemper Corporation was removed from several Russell 1000 and Midcap indices and simultaneously added to multiple Russell 2000, value, and defensive benchmarks. This shift effectively reclassifies Kemper from a larger-cap to a smaller-cap value-oriented peer group, potentially altering how many institutional investors view and hold the stock. We’ll now examine how Kemper’s move from Russell 1000 to Russell 2000 indices could influence its investment narrative and investor...

Vertex Pharmaceuticals agreed to acquire Crinetics Pharmaceuticals (NasdaqGS:CRNX) in an all cash deal valued at about US$10b. The boards of both companies approved the transaction unanimously. The deal is expected to close in Q3 2026, subject to regulatory and Crinetics shareholder approvals. Crinetics Pharmaceuticals focuses on endocrine diseases, an area where larger drug makers have been looking to expand their presence. Vertex is set to add Crinetics' pipeline and clinical expertise to...

In late June 2026, Sarepta Therapeutics reported that the FDA accepted for filing supplemental New Drug Applications to convert accelerated approvals for its Duchenne muscular dystrophy therapies AMONDYS 45 and VYONDYS 53 into traditional approvals, supported by Phase 3 ESSENCE data and extensive real‑world evidence. Although the ESSENCE trial did not meet its primary endpoint, treatment-favoring trends, long-term safety data and real-world functional benefits could materially influence how...

Arrow Electronics (ARW) has been removed from both the Russell 1000 Value Defensive Index and the Russell 1000 Defensive Index, a move that can affect how certain rules based and benchmark aware investors view the stock. See our latest analysis for Arrow Electronics. Despite being dropped from the Russell 1000 Value Defensive and Russell 1000 Defensive indices, Arrow Electronics’ recent performance has been mixed, with the share price showing a 33.9% 90 day share price return and a 75.0% year...